Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
2.240
-0.040 (-1.75%)
Dec 20, 2024, 4:00 PM EST - Market closed
Ventyx Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 61.77 | 51.58 | 64.82 | 70.79 | 0.24 | 0.31 |
Short-Term Investments | 213.06 | 200.64 | 253.12 | 187.79 | - | - |
Cash & Short-Term Investments | 274.83 | 252.22 | 317.94 | 258.58 | 0.24 | 0.31 |
Cash Growth | -8.64% | -20.67% | 22.96% | 105873.77% | -21.04% | - |
Prepaid Expenses | 14.18 | 12.13 | 12.75 | 4.44 | 0 | 0.04 |
Total Current Assets | 289.41 | 264.35 | 330.69 | 263.02 | 0.25 | 0.35 |
Property, Plant & Equipment | 10.62 | 12.27 | 1.94 | 0.25 | - | - |
Long-Term Investments | - | - | 38.67 | 28.15 | - | - |
Other Long-Term Assets | 1.07 | 1.08 | 0.1 | 0.06 | - | - |
Total Assets | 301.1 | 277.69 | 371.4 | 291.48 | 0.25 | 0.35 |
Accounts Payable | 2.29 | 5.76 | 6.43 | 4.66 | 1.1 | 0.36 |
Accrued Expenses | 9.01 | 15.51 | 9.51 | 7.62 | 0.3 | 0.27 |
Current Portion of Leases | 1.01 | 1 | 0.41 | - | - | - |
Total Current Liabilities | 12.3 | 22.27 | 16.36 | 12.28 | 1.4 | 0.63 |
Long-Term Debt | - | - | - | - | 12.65 | 3.85 |
Long-Term Leases | 10.03 | 11.51 | 1.15 | - | - | - |
Other Long-Term Liabilities | - | - | - | - | 16.85 | - |
Total Liabilities | 22.33 | 33.77 | 17.51 | 12.28 | 30.9 | 4.48 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | - | - |
Additional Paid-In Capital | 802.85 | 663.15 | 581.24 | 397.05 | 1.85 | 0.2 |
Retained Earnings | -524.96 | -419.19 | -226.23 | -117.8 | -32.5 | -4.33 |
Comprehensive Income & Other | 0.87 | -0.05 | -1.12 | -0.06 | - | - |
Shareholders' Equity | 278.77 | 243.92 | 353.9 | 279.2 | -30.65 | -4.13 |
Total Liabilities & Equity | 301.1 | 277.69 | 371.4 | 291.48 | 0.25 | 0.35 |
Total Debt | 11.04 | 12.51 | 1.56 | - | 12.65 | 3.85 |
Net Cash (Debt) | 263.79 | 239.71 | 355.06 | 286.72 | -12.4 | -3.54 |
Net Cash Growth | -8.56% | -32.49% | 23.83% | - | - | - |
Net Cash Per Share | 4.02 | 4.09 | 6.77 | 22.36 | -6.24 | -2.13 |
Filing Date Shares Outstanding | 70.71 | 59.24 | 58.17 | 50.73 | 2.06 | 1.66 |
Total Common Shares Outstanding | 70.67 | 59.24 | 56.98 | 50.41 | 2.06 | 1.66 |
Working Capital | 277.11 | 242.08 | 314.33 | 250.74 | -1.16 | -0.28 |
Book Value Per Share | 3.94 | 4.12 | 6.21 | 5.54 | -14.89 | -2.48 |
Tangible Book Value | 278.77 | 243.92 | 353.9 | 279.2 | -30.65 | -4.13 |
Tangible Book Value Per Share | 3.94 | 4.12 | 6.21 | 5.54 | -14.89 | -2.48 |
Machinery | 0.31 | 0.37 | 0.31 | 0.28 | - | - |
Construction In Progress | 0.04 | 0.16 | - | - | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.